About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2012 (2012), Article ID 981519, 7 pages
http://dx.doi.org/10.1155/2012/981519
Research Article

Seizures in Primary Antiphospholipid Syndrome: The Relevance of Smoking to Stroke

1Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, 01246-903 São Paulo, SP, Brazil
2Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de Campinas, Campinas, SP, Brazil

Received 20 November 2011; Accepted 14 January 2012

Academic Editor: Clelia M. Riera

Copyright © 2012 Jozélio Freire de Carvalho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Erkan and M. D. Lockshin, “New approaches for managing antiphospholipid syndrome,” Nature Clinical Practice Rheumatology, vol. 5, no. 3, pp. 160–170, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. G. R. V. Hughes, “Thrombosis, abortion, cerebral disease, and the lupus anticoagulant,” British Medical Journal, vol. 287, no. 6399, pp. 1088–1089, 1983. View at Scopus
  3. G. Ruiz-Irastorza, M. Crowther, W. Branch, and M. A. Khamashta, “Antiphospholipid syndrome,” The Lancet, vol. 376, no. 9751, pp. 1498–1509, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Erkan, M. J. Harrison, R. Levy et al., “Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals,” Arthritis and Rheumatism, vol. 56, no. 7, pp. 2382–2391, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Cervera, J.-C. Piette, J. Font et al., “Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients,” Arthritis and Rheumatism, vol. 46, no. 4, pp. 1019–1027, 2002. View at Publisher · View at Google Scholar · View at PubMed
  6. G. Sanna, M. L. Bertolaccini, M. J. Cuadrado, M. A. Khamashta, and G. R. V. Hughes, “Central nervous system involvement in the antiphospholipid (Hughes) syndrome,” Rheumatology, vol. 42, no. 2, pp. 200–213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. C. E. M. Rodrigues, J. F. Carvalho, and Y. Shoenfeld, “Neurological manifestations of antiphospholipid syndrome,” European Journal of Clinical Investigation, vol. 40, no. 4, pp. 350–359, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. J. Chapman, M. Cohen-Armon, Y. Shoenfeld, and A. D. Korczyn, “Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes,” Lupus, vol. 8, no. 2, pp. 127–133, 1999. View at Scopus
  9. Y. Shoenfeld, S. Lev, I. Blatt et al., “Features associated with epilepsy in the antiphospholipid syndrome,” Journal of Rheumatology, vol. 31, no. 7, pp. 1344–1348, 2004. View at Scopus
  10. H. H. Liou, C. R. Wang, H. C. Chou et al., “Anticardiolipin antisera from lupus patients with seizures reduce a GABA receptor-mediated chloride current in snail neurons,” Life Sciences, vol. 54, no. 15, pp. 1119–1125, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Cocito, E. Favale, and L. Reni, “Epileptic seizures in cerebral arterial occlusive disease,” Stroke, vol. 13, no. 2, pp. 189–195, 1982. View at Scopus
  12. R. A. Asherson, M. A. Khamashta, A. Gil et al., “Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome,” American Journal of Medicine, vol. 86, no. 4, pp. 391–399, 1989. View at Scopus
  13. S. Miyakis, M. D. Lockshin, T. Atsumi et al., “International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS),” Journal of Thrombosis and Haemostasis, vol. 4, no. 2, pp. 295–306, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. I. M. Benseñor, P. A. Lotufo, P. R. Menezes, and M. Scazufca, “Subclinical hyperthyroidism and dementia: the Sao Paulo ageing & Health study (SPAH),” BMC Public Health, vol. 10, p. 298, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. “The IDF consensus worldwide definition of the metabolic syndrome,” International Diabetes Federation, 2006, http://www.idf.org/metabolic_syndrome_def.pdf.
  16. W. T. Blume, H. O. Lüders, E. Mizrahi, C. Tassinari, W. Van Emde Boas, and J. Engel Jr, “Glossary of descriptive terminology for ictal semiology: report of the ILAE Task Force on classification and terminology,” Epilepsia, vol. 42, no. 9, pp. 1212–1218, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Fisher, W. van Emde Boas, W. Blume et al., “Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE),” Epilepsia, vol. 46, no. 4, pp. 470–472, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Appenzeller, F. Cendes, and L. T. L. Costallat, “Epileptic seizures in systemic lupus erythematosus,” Neurology, vol. 63, no. 10, pp. 1808–1812, 2004. View at Scopus
  19. S. S. Pierangeli and E. N. Harris, “A protocol for determination of anticardiolipin antibodies by ELISA,” Nature Protocols, vol. 3, no. 5, pp. 840–848, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. F. Wisloff, E. M. Jacobsen, and S. Liestol, “Laboratory diagnosis of the antiphospholipid syndrome,” Thrombosis Research, vol. 108, no. 5-6, pp. 263–271, 2002. View at Publisher · View at Google Scholar
  21. R. H. Esparza, T. Swaak, L. Aarden, and R. Smeenk, “Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal,” Journal of Rheumatology, vol. 12, no. 6, pp. 1109–1117, 1985. View at Scopus
  22. E. M. Tan and C. Peebles, “Quantitation of antibodies to Sm antigen and nuclear ribonucleoprotein by hemagglutination,” in Manual of Clinical Immunology, N. R. Rose and H. Friedman, Eds., pp. 866–870, American Society of Microbiology, Washington, DC, USA, 2nd edition, 1980.
  23. B. A. Dworetzky, E. B. Bromfield, M. K. Townsend, and J. H. Kang, “A prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: data from the Nurses' Health Study II,” Epilepsia, vol. 51, no. 2, pp. 198–205, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. C. M. de Fiebre and A. C. Collins, “Decreased sensitivity to nicotine-induced seizures as a consequence of nicotine pretreatment in long-sleep and short-sleep mice,” Alcohol, vol. 5, no. 1, pp. 55–61, 1988. View at Scopus
  25. R. S. Broide, R. Salas, D. Ji et al., “Increased sensitivity to nicotine-induced seizures in mice expressing the L250t α7 nicotinic acetylcholine receptor mutation,” Molecular Pharmacology, vol. 61, no. 3, pp. 695–705, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. R. W. Sanders, K. D. Katz, J. Suyama et al., “Seizure during hyperbaric oxygen therapy for carbon monoxide toxicity: a case series and five-year experience,” Journal of Emergency Medicine, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. M. R. Arbuckle, M. T. McClain, M. V. Rubertone et al., “Development of autoantibodies before the clinical onset of systemic lupus erythematosus,” New England Journal of Medicine, vol. 349, no. 16, pp. 1526–1533, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. R. Ribeiro and J. F. Carvalho, “Traditional risk factors for cardiovascular disease in primary antiphospholipid syndrome (APS) when compared with secondary APS: a study with 96 patients,” Acta Reumatologica Portuguesa, vol. 35, no. 1, pp. 36–41, 2010. View at Scopus
  29. R. Gualtierotti, M. Biggioggero, and P. L. Meroni, “Cutting-edge issues in coronary disease and the primary antiphospholipid syndrome,” Clinical Reviews in Allergy and Immunology. In press. View at Publisher · View at Google Scholar · View at PubMed
  30. P. M. Moore and R. P. Lisak, “Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction,” Springer Seminars in Immunopathology, vol. 17, no. 1, pp. 43–60, 1995. View at Scopus